Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1989 Jul;60(1):149. doi: 10.1038/bjc.1989.238

Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect.

J T Beranek
PMCID: PMC2247353  PMID: 2478179

Full text

PDF

Page 149

149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen N. T., Corey E. J., Folkman J. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase. Lab Invest. 1988 Oct;59(4):453–459. [PubMed] [Google Scholar]
  2. Rubens R. D., Tinson C. L., Coleman R. E., Knight R. K., Tong D., Winter P. J., North W. R. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer. Br J Cancer. 1988 Nov;58(5):626–630. doi: 10.1038/bjc.1988.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Shulman A. G. Heparin for prevention of atherosclerosis. N Engl J Med. 1988 Oct 27;319(17):1154–1155. doi: 10.1056/NEJM198810273191710. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES